特发性血小板减少性紫癜病因与发病机制的研究进展(4)
[11]Houwerzijl EJ，Blom NR，van der Want JJ，et al.Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombo-cytopenic purpura[J].Blood，2004，103(2):500-506.
[12]王琼玉.高清平细胞凋亡和增殖在特发性血小板减少性紫癜中的作用[J].临床内科杂志，2003，20(8):421.
[13]Ogawara H，Handa H，Morita K，et al.Hight Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura[J].Eur J Haematol，2003，71:283-288.
[14]Yoshimura C， Nomura S， Nagahama M，et al. Plasma-soluble Fas (APO-1， CD95)and soluble Fas ligand in immune thrombocytopenic purpura[J]. Eur J Haematol，2000， 64(4): 219-224.
[15]Olsson B，Andersson PO，Jernas M，et al.T-cell-mediated cytotoxicitytoward platelets in chronic idiopathic thrombocytopenic Purpura[J].Nat Med，2003，9:1123.
[16]Webber NP，Mascareenhas JO，Crow MK，et al.Funtional properties of lymphocytes in idiopathic thrombocytopenic purpura[J].Hum Immunol，2001，62:1346-1355.
[17]Cui G，Liu X，Yao J.The effect of costimulatory factors in the pathogenesis of chronic idiopathic thrombocytopenic purpura[J]. Huazhong Univ Sci Technolog Med Sci， 2003， 23(4): 352-355.
[18]曾艳，高清平，陈友华，等.特发性血小板减少性紫癜患者外周血来源树突细胞的功能研究[J].中华血液学杂志，2005，26(3): 182-183.
[19]高清平，曾艳，王琼玉，等.特发性血小板减少性紫癜患者B淋巴细胞的特征[J].中华微生物学和免疫学杂志，2005，25(3): 247.
[20]Peng J， Liu C， Liu D， et al. Effects of B7-blocking agent and/or CsA on induction of platelet-specificT-cellanergyinchronic autoimmune thrombocytopenic purpura[J]. Blood， 2003，101(7):2721-2726.
[21]伏瑞祥，吴德沛.CD4+CD25+T细胞在ITP 发病中的作用[J].现代免疫学杂志， 2004， 24 :32.
[22]Zhan M， Zhao H， Yang R， et al. Serum leptin levels in patients with idiopath icthrombocyto- penic purpura[J]. Eur J Haematol， 2004， 72(5):348-52.
[23]Sanna V，Di Giacomo A，La Cava A，et al.Leptin surge precedes onset ofautoimmune encep- halomyelitis and correlates with development of pathogenic T cellresponses[J]. J Clin Invest， 2003，111(2): 241-250.
(收稿日期：2008-03-26)
, http://www.100md.com(龙珍珠玛 郎 涛 王 燕 徐全晓)
[12]王琼玉.高清平细胞凋亡和增殖在特发性血小板减少性紫癜中的作用[J].临床内科杂志，2003，20(8):421.
[13]Ogawara H，Handa H，Morita K，et al.Hight Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura[J].Eur J Haematol，2003，71:283-288.
[14]Yoshimura C， Nomura S， Nagahama M，et al. Plasma-soluble Fas (APO-1， CD95)and soluble Fas ligand in immune thrombocytopenic purpura[J]. Eur J Haematol，2000， 64(4): 219-224.
[15]Olsson B，Andersson PO，Jernas M，et al.T-cell-mediated cytotoxicitytoward platelets in chronic idiopathic thrombocytopenic Purpura[J].Nat Med，2003，9:1123.
[16]Webber NP，Mascareenhas JO，Crow MK，et al.Funtional properties of lymphocytes in idiopathic thrombocytopenic purpura[J].Hum Immunol，2001，62:1346-1355.
[17]Cui G，Liu X，Yao J.The effect of costimulatory factors in the pathogenesis of chronic idiopathic thrombocytopenic purpura[J]. Huazhong Univ Sci Technolog Med Sci， 2003， 23(4): 352-355.
[18]曾艳，高清平，陈友华，等.特发性血小板减少性紫癜患者外周血来源树突细胞的功能研究[J].中华血液学杂志，2005，26(3): 182-183.
[19]高清平，曾艳，王琼玉，等.特发性血小板减少性紫癜患者B淋巴细胞的特征[J].中华微生物学和免疫学杂志，2005，25(3): 247.
[20]Peng J， Liu C， Liu D， et al. Effects of B7-blocking agent and/or CsA on induction of platelet-specificT-cellanergyinchronic autoimmune thrombocytopenic purpura[J]. Blood， 2003，101(7):2721-2726.
[21]伏瑞祥，吴德沛.CD4+CD25+T细胞在ITP 发病中的作用[J].现代免疫学杂志， 2004， 24 :32.
[22]Zhan M， Zhao H， Yang R， et al. Serum leptin levels in patients with idiopath icthrombocyto- penic purpura[J]. Eur J Haematol， 2004， 72(5):348-52.
[23]Sanna V，Di Giacomo A，La Cava A，et al.Leptin surge precedes onset ofautoimmune encep- halomyelitis and correlates with development of pathogenic T cellresponses[J]. J Clin Invest， 2003，111(2): 241-250.
(收稿日期：2008-03-26)
, http://www.100md.com(龙珍珠玛 郎 涛 王 燕 徐全晓)